Trametinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Trametinib and local guidelines before prescribing.

MEK inhibitor

Mechanism

MEK inhibitor.

Uses

BRAF V600 melanoma and other cancers (with dabrafenib).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Rash, diarrhoea, cardiomyopathy, pyrexia, eye toxicity.

Interactions

Few.

Contraindications and cautions

Pregnancy

Monitoring

LVEF, eyes

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in hepatic impairment

Overdose and reversal

Supportive

Special advice

Combination fever pathway.

More from the textbook: uses, cautions and other points
Where it is discussed in the book